Foley Awarded 2013 M&A Advisor Deal of the Year in Healthcare/Life Sciences Category

20 December 2013 Media Contact: Jill Chanen News
Foley is pleased to announce that the firm’s work with OxOnc Development LP, was awarded “Deal of the Year in the Healthcare/Life Sciences (between $10 million to $50 million)” category at the 12th annual M&A Advisor awards gala on December 17, 2013. Foley attorneys, along with investment bankers MTS Health Partners, assisted in the formation and financing of OxOnc Development LP and its simultaneous entry into a significant development relationship with Pfizer, Inc. for the clinical development in the Peoples’ Republic of China, Japan, Taiwan and South Korea of Pfizer’s product, Xalkori, for the treatment of certain varieties of lung cancer. The Foley team consisted of Selig Sacks, Rick Kaufman, Jamshed Patel, Michael Dana and Melisande Brodeur-Frohman.

The M&A Advisor Awards recognize the leading dealmakers, firms and transactions.

Related Services

Insights

When Birds Finally Find a Nest
17 September 2019
Dashboard Insights
Upcoming Webinar: Maximizing Solar Tax Credits - Navigating the Start of Construction Rules (Part 1)
17 September 2019
Renewable Energy Outlook
DHS Moves Closer to Launching its H-1B Cap Registration System
16 September 2019
Labor & Employment Law Perspectives
Be Aware of Potential Legal Restrictions When Implementing a Workplace Weapons Policy
16 September 2019
Labor & Employment Law Perspectives
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.